Clinical Trial: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07448155) titled 'A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants' on Feb. 26.

Brief Summary: This study is being conducted to evaluate the pharmacokinetics, safety, and tolerability of INCA033989 following subcutaneous (SC) or intravenous administration (IV) n healthy adult participants.

Study Start Date: March 19

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: INCA033989

INCA033989 will be administered at protocol defined dose.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Incyte Corporation ...